Immunogen: Q1 Earnings Insights


Immunogen IMGN reported its Q1 earnings results on Friday, May 6, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.


Immunogen beat estimated earnings by 52.38%, reporting an EPS of $-0.1 versus an estimate of $-0.21.

Revenue was up $22.37 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $1.54 which was followed by a 7.44% increase in the share price the next day.

Here's a look at Immunogen's past performance:


Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -1.71 -0.18 -0.18 -0.19
EPS Actual -0.17 -0.18 -0.15 -0.17
Revenue Estimate 25.65M 19.03M 18.92M 17.73M
Revenue Actual 27.99M 9.21M 16.95M 15.71M

To track all earnings releases for Immunogen visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps